BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 22946011)

  • 1. Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.
    Ran S; Montgomery KE
    Cancers (Basel); 2012 Sep; 4(3):618-57. PubMed ID: 22946011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic Endothelial Cell Progenitors in the Tumor Microenvironment.
    Ran S; Volk-Draper L
    Adv Exp Med Biol; 2020; 1234():87-105. PubMed ID: 32040857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th2 Cytokines IL-4, IL-13, and IL-10 Promote Differentiation of Pro-Lymphatic Progenitors Derived from Bone Marrow Myeloid Precursors.
    Espinosa Gonzalez M; Volk-Draper L; Bhattarai N; Wilber A; Ran S
    Stem Cells Dev; 2022 Jun; 31(11-12):322-333. PubMed ID: 35442077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
    Lala PK; Nandi P; Majumder M
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment restricts IL-10 induced multipotent progenitors to myeloid-lymphatic phenotype.
    Volk-Draper L; Athaiya S; Espinosa Gonzalez M; Bhattarai N; Wilber A; Ran S
    PLoS One; 2024; 19(4):e0298465. PubMed ID: 38640116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophages induce capillary morphogenesis of lymphatic endothelial cells derived from human gastric cancer.
    Tauchi Y; Tanaka H; Kumamoto K; Tokumoto M; Sakimura C; Sakurai K; Kimura K; Toyokawa T; Amano R; Kubo N; Muguruma K; Yashiro M; Maeda K; Ohira M; Hirakawa K
    Cancer Sci; 2016 Aug; 107(8):1101-9. PubMed ID: 27227358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-Derived Lymphatic Endothelial Cell Progenitors Significantly Contribute to Lymphatic Metastasis in Clinical Breast Cancer.
    Volk-Draper L; Patel R; Bhattarai N; Yang J; Wilber A; DeNardo D; Ran S
    Am J Pathol; 2019 Nov; 189(11):2269-2292. PubMed ID: 31421071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors.
    Ran S; Wilber A
    J Leukoc Biol; 2017 Aug; 102(2):253-263. PubMed ID: 28408396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer.
    Bieniasz-Krzywiec P; Martín-Pérez R; Ehling M; García-Caballero M; Pinioti S; Pretto S; Kroes R; Aldeni C; Di Matteo M; Prenen H; Tribulatti MV; Campetella O; Smeets A; Noel A; Floris G; Van Ginderachter JA; Mazzone M
    Cell Metab; 2019 Nov; 30(5):917-936.e10. PubMed ID: 31447322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangiogenesis and lymphatic metastasis in breast cancer.
    Ran S; Volk L; Hall K; Flister MJ
    Pathophysiology; 2010 Sep; 17(4):229-51. PubMed ID: 20036110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
    Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4.
    Volk-Draper LD; Hall KL; Wilber AC; Ran S
    PLoS One; 2017; 12(6):e0179257. PubMed ID: 28598999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
    Harris AR; Perez MJ; Munson JM
    BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer.
    Kurahara H; Takao S; Maemura K; Mataki Y; Kuwahata T; Maeda K; Sakoda M; Iino S; Ishigami S; Ueno S; Shinchi H; Natsugoe S
    Pancreas; 2013 Jan; 42(1):155-9. PubMed ID: 22699204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm.
    Kim KE; Koh YJ; Jeon BH; Jang C; Han J; Kataru RP; Schwendener RA; Kim JM; Koh GY
    Am J Pathol; 2009 Oct; 175(4):1733-45. PubMed ID: 19762711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.
    Schoppmann SF; Birner P; Stöckl J; Kalt R; Ullrich R; Caucig C; Kriehuber E; Nagy K; Alitalo K; Kerjaschki D
    Am J Pathol; 2002 Sep; 161(3):947-56. PubMed ID: 12213723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New model of macrophage acquisition of the lymphatic endothelial phenotype.
    Hall KL; Volk-Draper LD; Flister MJ; Ran S
    PLoS One; 2012; 7(3):e31794. PubMed ID: 22396739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.